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undergo enhanced recruitment and
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increasing age, dorsal OPs become less
able to differentiate into mature
oligodendrocytes.
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Oligodendrocyte progenitors (OPs) arise fromdistinct
ventral and dorsal domains within the ventricular
germinal zones of the embryonic CNS. The functional
significance, if any, of these different populations is
not known. Using dual-color reporter mice to distin-
guish ventrally and dorsally derived OPs, we show
that, in response to focal demyelination of the young
adult spinal cord or corpus callosum, dorsally derived
OPs undergo enhanced proliferation, recruitment,
and differentiation as compared with their ventral
counterparts,making aproportionally larger contribu-
tion to remyelination. However, with increasing age
(up to 13 months), the dorsally derived OPs become
less able to differentiate into mature oligodendro-
cytes. Comparison of dorsally and ventrally derived
OPs in culture revealed inherent differences in their
migration and differentiation capacities. Therefore,
the responsiveness of OPs to demyelination, their
contribution to remyelination, and their susceptibility
to age-associated functional decline are markedly
dependent on their developmental site of origin in
the developing neural tube.
INTRODUCTION
Enhancing the regeneration of myelin sheaths in the CNS is an
important therapeutic goal in the management of demyelinating
disease (Franklin and Gallo, 2014). Myelin sheaths facilitate effi-
cient neurotransmission and provide trophic support to the axon,
crucial to the maintenance of axonal integrity (Nave and Werner,
2014). Loss of myelin results in conduction block in the short
term and axonal degeneration in the longer term (Franklin
et al., 2012). Myelin regeneration, or remyelination, is mediated
by oligodendrocyte progenitors (OPs) distributed throughout
the CNS. OPs become activated in response to demyelination
and are recruited to the damaged area where they differentiate
into oligodendrocytes (OLs) (Levine and Reynolds, 1999; Tripathi
et al., 2010; Zawadzka et al., 2010; Moyon et al., 2015). TheThis is an open access article under the CC BY-Nnewly differentiated OLs establish contact with exposed axons
and ultimately generate new myelin sheaths. This process can
be highly efficient, enabling complete reconstruction of the orig-
inal tissue architecture and full functional recovery. However, ag-
ing is associated with a declining rate of remyelination and, in
chronic disease, remyelination frequently fails due to insufficient
OP differentiation (reviewed by Franklin et al., 2012). This failure
of remyelination is a major contributor to disease progression
and represents a significant barrier to the effective treatment of
chronic demyelinating diseases. The development of effective
remyelination-enhancing therapeutic strategies necessitates a
detailed understanding of the biology of OPs and the mecha-
nisms of their differentiation block in aging and disease (Huang
et al., 2011).
Despite the widespread distribution of OPs throughout the
CNS, the founder cells of the lineage are spatially localized in
the developing neural tube and emerge as regionally and tempo-
rally discrete populations (reviewed by Richardson et al., 2006;
Bergles and Richardson, 2015). In the developing mouse spinal
cord, OPs initially arise around embryonic day 12.5 (E12.5)
from the ventral ventricular zone (VZ), under the control of Sonic
Hedgehog (Shh) from the notochord and floor plate (Pringle and
Richardson, 1993; Pringle et al., 1996). From E15.5, a second
wave of OPs emerges from the dorsal VZ, independent of Shh
signaling (Cai et al., 2005; Fogarty et al., 2005; Vallstedt et al.,
2005), contributing 20% of the total OP population (Tripathi
et al., 2011). Most dorsally derived OPs remain in the dorsal
half of the cord, while the ventrally derived OPs spread widely
throughout the cross-section of the cord (Tripathi et al., 2011;
Zhu et al., 2011). As a result, the dorsal and dorso-lateral funiculi
are initially populated by a mixture of dorsally and ventrally
derived OL lineage cells. Subsequently, ventrally derived cells
are displaced, through an unknownmechanism, by their dorsally
derived counterparts so that the corticospinal and rubrospinal
tracts, for example, become myelinated mainly by dorsally
derived OLs (Tripathi et al., 2011).
In the developing forebrain, spatially distinct sources of OPs
have also been identified. The first OPs appear around E12.5,
emerging from Nkx2.1-expressing progenitor cells in the medial
ganglionic eminence (MGE) and anterior entopeduncular area in
the ventral telencephalon (forerunner of the forebrain). Subse-
quently, from around E15.5, OPs emerge from Gsh2-expressingCell Reports 15, 761–773, April 26, 2016 ª2016 The Authors 761
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progenitors of the lateral and caudal ganglionic eminences (LGE
and CGE). Finally, from around the time of birth (postnatal day
zero, P0), OPs start to be generated by Emx1-expressing pro-
genitors in the cortical VZ. The initial wave of Nkx2.1-domain
derived OPs is largely eliminated from the postnatal cortex,
implying competition among the different populations or an
ongoing turnover with preferential replacement of earlier-formed
cells by their later-forming counterparts (Kessaris et al., 2006).
OLswith different spatial origins, possibly specified via different
transcriptional regulators, might have distinct properties and
functions in the mature brain. To investigate this possibility, we
have generated a dual-reporter mouse line Sox10-lox-eGFP-
STOP-lox-TdTomato (referred to as Sox10-GFP-TdTom) that al-
lows OL lineage cells derived from different VZ domains to be
distinguished by color (Tripathi et al., 2011). In the absence of
Cre recombinase, all OPs and their OL progeny (Sox10-express-
ing) express GFP by default; exposure to Cre triggers recombina-
tion and activates tandem-duplicated Tomato (TdTom) expres-
sion instead. For example, crossing to Msx3-Cre mice (Fogarty
et al., 2005) induces TdTom expression only in those OL lineage
cells that are derived from the dorsal spinal cord and brainstem
(Tripathi et al., 2011), while Emx1-Cre (Kessaris et al., 2006) in-
duces TdTom only in OL lineage cells that originate within the
developing cerebral cortex (Tripathi et al., 2011).
Both in the forebrain and spinal cord there is competition be-
tween dorsally and ventrally derived OL lineage cells. In the spi-
nal cord, dorsally derived cells displace their ventrally derived
relatives from dorsal axon tracts during postnatal life (Tripathi
et al., 2011). In the forebrain, OL lineage cells derived from the
MGE (Nkx2.1-expressing) migrate into the cortex before birth,
but are largely eliminated after birth and superseded by cells
from more dorsal territories (Gsh2- and Emx1-expressing; Kes-
saris et al., 2006). Prompted by the study by Zhu et al. (2011),
which drew attention to the remyelinating capacity of dorsally
derived cells, we asked whether this inter-regional competition
is also evident during remyelination. We induced acute focal
demyelination in the ventral funiculus of the spinal cord or in
the corpus callosum by targeted lysolecithin injection and fol-
lowed remyelination of the lesions using the two-color reporter
system described above.We found that dorsally derived OL line-
age cells dominate the remyelination response in both ventral
spinal cord and corpus callosum. However, the dorsally derived
cells showed an accelerated age-related impairment in their abil-
ity to differentiate into myelinating OLs compared to their
ventrally derived counterparts. When cultured in vitro, the two
populations demonstrated inherent differences in their migration
and differentiation capacities and these functional differences
were greater in adult brain-derived cells compared to cells
from neonatal brain. Thus, we provide evidence that the devel-
opmental origin of OL lineage cells influences their regenerative
properties in adulthood.
RESULTS
Dorsally Derived OL Lineage Cells Dominate
Remyelination in the Young Adult Spinal Cord
2-month-old (P58–P74, mean age P68) mice carrying theMsx3-
Cre and Sox10-GFP-TdTom transgenes were used for spinal762 Cell Reports 15, 761–773, April 26, 2016cord experiments. In Msx3-Cre: Sox10-GFP-TdTom spinal
cords Sox10-expressing OPs and OLs derived from the ventral
VZ are labeled constitutively with enhanced GFP, while dorsally
derived OPs/OLs are labeled with TdTom (Tripathi et al., 2011).
Immunolabeling spinal cord sections for the OL lineage marker
Olig2 revealed that 94.7 ± 1.6% of all reporter-positive cells
(either TdTom+ or GFP+) were also Olig2+, and that 96 ± 1.8%
of Olig2+ cells were either TdTom+ or GFP+, confirming specific
labeling of OL lineage cells in the adult CNS (Tripathi et al., 2011
and data not shown).
To determine the percentage of TdTom+ and GFP+ cells
remaining as OPs in the non-lesioned spinal cord, immunofluo-
rescent staining was performed for NG2, a surface proteoglycan
found on OPs, 14.3 ± 3.9% of TdTom+ cells co-labeled with
NG2, compared to 2.8 ± 0.9% of GFP+ cells (p = 0.005;
Student’s t test). To determine the percentage of cells that differ-
entiated into mature OLs, labeling for CC1 was performed,
41.3 ± 0.8% of TdTom+ cells co-labeled with CC1+, compared
with 91.3 ± 1.1% (p = 0.003; Student’s t test).
Demyelination was induced by the injection of lysolecithin into
the ventral funiculus of the spinal cord. This induced a small focal
area of demyelination which undergoes a characteristic pattern
of remyelination: OP recruitment peaks around 5 days post-
lesion (dpl), differentiation into myelin sheath-forming OLs
commences around 10 dpl, and continues until remyelination
is complete in young adult mice at around 21 dpl (Arnett et al.,
2004). In the non-lesioned ventral funiculus, there were only
63 ± 8 TdTom+ cells/mm2 compared to 302 ± 11 GFP+
cells/mm2. Following induction of demyelination in the ventral
funiculus, the number of TdTom+ cells increased in the lesion pe-
riphery at 5 dpl, appeared in the lesion core by 10 dpl, and were
abundant throughout the lesioned area by 21 dpl (Figures 1A–
1C). Cell counts confirmed that the number of TdTom+ cells
within the lesion changed significantly over time, yet there was
no significant change in the number of GFP+ cells (Figure 1D).
By 60 dpl, the TdTom+ cells had increased in number 9-fold
and had become the dominant population of OL lineage cells
within the lesioned area (557 ± 45 TdTom+ cells/mm2 compared
to 364 ± 55 GFP+ cells/mm2).
Dorsally Derived OPs Proliferate in Response to Focal
Demyelination
To assess cell proliferation in lesions and the surrounding tissue,
we immunolabeled for the nuclear antigen Ki67, which is ex-
pressed through all phases of the cell cycle except early G1/
G0. We found that TdTom+/Ki67+ cells were more numerous
than GFP+/Ki67+ cells at both 5 dpl and 10 dpl, after which,
numbers of Ki67+ cells declined to baseline levels (Figure 1E).
This indicates that a greater fraction of dorsally derived OPs
(dOPs) was mitotically active compared to their ventrally derived
counterparts (vOPs).
To determine whether vOPs undergo an early or late prolifera-
tive response that we failed to detect at 5 dpl or 10 dpl, we per-
formed a time course of EdU incorporation. Following lysoleci-
thin injection into the spinal cord (ventral funiculus), mice were
given EdU by intraperitoneal injection on 2 consecutive days
starting at 1, 3, 5, or 7 dpl and analyzed 24 hr after the second
EdU dose (on 3, 5, 7, or 9 dpl). From 3 dpl to 7 dpl, proportionally
Figure 1. Increased Recruitment of dOPs
versus vOPs into a Demyelinated Lesion in
the Ventral Funiculus of the Spinal Cord
(A) Schematic depiction of the location of lysolec-
ithin injection into the ventral funiculus of the
caudal thoracic spinal cord.
(B and C) Immunolabeling of the non-lesioned (B,
inset) and lesioned ventral funiculus of the caudal
thoracic spinal cord at 5 dpl (B) and 21 dpl (C). The
TdTom+ dOPs are infrequent in the non-lesioned
ventral funiculus, but increase in number within the
lesion (marked by the white dashed line).
(D) Increase in TdTom+ dOL lineage cells following
demyelination in the ventral funiculus (p < 0.001,
5–10 dpl; p = 0.023, 21–60 dpl; and one-way
ANOVA and Tamhane post hoc test). There is no
equivalent change in the number of GFP+ vOL
lineage cells (p = 0.76).
(E) There are significantly more TdTom+/Ki67+
cells than GFP+/Ki67+ cells at 5 dpl (p = 0.006 and
Student’s t test) and 10 dpl (p = 0.001).
(F) A significantly greater proportion of TdTom+
cells were also EdU+ on days 1/2 (p = 0.017 and
one-way ANOVA and Tamhane post hoc test),
days 3/4 (p = 0.003), and days 5/6 (p < 0.001),
compared to GFP+ cells.
(G–I) EdU was administered on days 3/4 and the
animal sacrificed at 5 dpl. Abundant EdU+ cells are
seen within the lesion and the immediately sur-
rounding area (G). Almost no EdU+/TdTom+ or
GFP+ cells were detected in the dorsal funiculus
(H) or lateral funiculus (I). The data are presented as
mean ± SEM (n = 3mice). The scale bars represent
100 mm (*p < 0.05, **p < 0.01, and ***p < 0.001).more TdTom+ dOPs than GFP+ vOPs incorporated EdU (Fig-
ure 1F). EdU+ cells were observed within the demyelinated
lesion and the immediately surrounding area (Figure 1G). Very
few EdU+ cells were detected in the contralateral ventral funic-
ulus, dorsal funiculus, or lateral funiculi (Figures 1H and 1I), indi-
cating that the prominent recruitment of dOPs into the lesioned
ventral funiculus is the result of a local proliferative response.
dOPs Undergo Enhanced OL Differentiation into
Remyelinating OLs and Schwann Cells in Spinal Cord
Lesions Relative to vOPs
We compared the differentiation capacities of dOPs and vOPs
by immunolabeling for the CC1 antigen, which is expressed by
mature OLs. The number of TdTom+, CC1+ dOLs increased
greatly between 5 dpl and 60 dpl, so that the density of dOLs
became >10-fold higher than it had been pre-lesion (Figures
2A and 2B). In contrast, the density of GFP+, CC1+ vOLs initially
decreased, but recovered to approximately the pre-lesion level
(Figure 2A). Thus, the enhanced proliferation of dOPs relative
to vOPs is mirrored by an increased rate of differentiation of
dOPs into CC1+ OLs in the lesion.
Schwann cells contribute to CNS remyelination following lyso-
lecithin-induced demyelination, and themajority of remyelinating
Schwann cells are generated by centrally derived OPs (Za-
wadzka et al., 2010). To determine the relative contributions of
dOPs and vOPs to Schwann cell differentiation, the lesioned tis-sue was immunolabeled for Oct6/SCIP, a transcription factor ex-
pressed by pre-myelinating Schwann cells, and Periaxin, a pro-
tein of myelinating Schwann cells (Sim et al., 2002a). Of the
Oct6+ cells present within the lesioned area at 5 dpl or 10 dpl,
more were TdTom+ than GFP+ (Figures 2C and 2D) and more
Periaxin+ cells were TdTom+ than GFP+ at 21 dpl and 60 dpl
(Figures 2E and 2F). For example, on 60 dpl, 37% ± 4% of
TdTom+ cells expressed Periaxin, compared with 22% ± 3%
of GFP+ cells, while 58% ± 4% of Periaxin+ cells were TdTom+
and 42% ± 4% were GFP+. Therefore, more remyelinating
Schwann cells are generated by TdTom+ dOPs than by GFP+
vOPs.
Dorsally Derived OLs Dominate Remyelination of the
Young Adult Corpus Callosum
In the developing forebrain, OPs have been shown to emerge
from the VZ in a ventral-to-dorsal wave from distinct VZ terri-
tories marked by expression of transcription factors Nkx2.1,
Gsh2, and Emx1 (Kessaris et al., 2006). Nkx2.1 and Gsh2 are
expressed in the MGE and LGE of the ventral forebrain, res-
pectively, while Emx1 is expressed in the cortical VZ (dorsal
forebrain). To study the relative properties of OPs derived from
the ventral forebrain and the cortex, the Sox10-GFP-TdTom re-
porter was crossed onto the Emx1-Cre background. In double-
transgenic offspring, Emx1+ dOPs (and their dOL derivatives)
express TdTom, while vOPs and vOLs from the MGE and LGECell Reports 15, 761–773, April 26, 2016 763
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Figure 2. OLs and Schwann Cell Generation by dOPs and vOPs
during Remyelination of Spinal Cord Demyelination
(A) There is a significant increase in TdTom+, CC1+ cells between non-
lesioned and lesioned tissue at 21 dpl (p = 0.001 and one-way ANOVA and
Tamhane), whereas GFP+, CC1+ cells do not change in number significantly.
(B) Numerous TdTom+/CC1+ cells are present within the remyelinated area.
(C) There are significantly more TdTom+/Oct6+ cells than GFP+/Oct6+ cells in
lesions at 5 dpl (p = 0.042 and Student’s t test) and 10 dpl (p = 0.036).
(D) Oct6+/TdTom+ cells within the lesioned area.
(E) There are significantly more TdTom+/Periaxin+ cells than GFP+/Periaxin+
cells in lesions at 21 dpl (p < 0.001 and Student’s t test) and 60 dpl (p = 0.045).
(F) A cluster of Periaxin+ Schwann cells within the core of the remyelinated
area, the majority of which co-label for TdTom. The data are presented as
mean ± SEM (n = 3 mice). The scale bars represent 50 mm.constitutively express GFP. We found that 88% ± 10% of re-
porter-positive cells (either TdTom+ or GFP+) in the adult corpus
callosum co-labeled for Olig2, and 100% ± 1% of Olig2+ cells
expressed either TdTom or GFP (data not shown), confirming
specific labeling of OL lineage cells.
Focal demyelination was induced by lysolecithin injection into
the corpus callosum of 2-month-old mice (P64–P84, mean age
P75) and the ensuing remyelination, which undergoes a similar
timeline of remyelination to spinal cord demyelination (Miron
et al., 2013), was analyzed as described above for spinal cord.
TdTom+ (cortex-derived) dOPs and dOLs were significantly
more numerous than GFP+ vOPs and vOLs within the normal764 Cell Reports 15, 761–773, April 26, 2016corpus callosum (782 ± 185 cells/mm2 versus 117 ± 37 GFP+
cells/mm2, respectively) (Figures 3A and 3D). Following lysolec-
ithin injection, TdTom+ cells were initially depleted (5 dpl), but
their numbers increased subsequently, recovering to non-
lesioned control cell densities by 21 dpl (Figures 3B–3D). GFP+
cells, in contrast, did not much change during demyelination/re-
myelination (Figure 3D).
Within the lesioned area of corpus callosum, the number of
proliferating Ki67+ cells, both TdTom+ and GFP+, changed
over time, first increasing then decreasing to pre-lesion levels
(Figure 3E). The proliferative response of TdTom+ dOPs was
more rapid than GFP+ vOPs, but their overall responses were
similar (Figure 3E).
TdTom+, CC1+ dOLs were initially depleted (at 5 dpl), but
recovered to their pre-lesion density by 21 dpl (Figure 3F).
Both before lesioning and after recovery at 21 dpl and 60 dpl,
TdTom+, CC1+ dOLs greatly outnumbered their ventrally
derived counterparts, effectively dominating the remyelination
response (Figure 3F). Unlike spinal cord lesions, Oct6+ or Peri-
axin+ Schwann cells were not detected in remyelinating corpus
callosum lesions.
dOPs Outperform vOPs in their Response to
Demyelination in the Aging Spinal Cord
The efficiency of remyelination declines with age, and this has
been associated with a reduction in the remyelinating capacity
of OPs (Shields et al., 1999; Sim et al., 2002b; Shen et al.,
2008). To investigate whether the developmental origin of
OPs influences age-associated functional decline, focal demye-
lination was induced in the spinal cord (ventral funiculus)
of 6-month-old mice (P176–P186, mean age P184) and 13-
month-old mice (P388–P419, mean age P401). Mice were sacri-
ficed at 5 dpl, 10 dpl, or 21 dpl. In 13-month-old mice, 92% ± 2%
of Olig2+ cells were either TdTom+ or GFP+, confirming that
the transgene continued to be expressed efficiently in the older
spinal cord.
The number of TdTom+ dOL lineage cells in the non-lesioned
ventral funiculus increasedmodestly (2-fold) between 2months
and 13months (Figure 4A). Following demyelination at 2 months,
6 months, or 13 months, the number of dOL lineage cells first
decreased then increased markedly from pre-lesion levels,
reaching a plateau in 2-month-old animals at 10 dpl, but
continuing to increase in 6-month- and 13-month-old animals
until at least 21 dpl (Figure 4A). In contrast, the number of
GFP+ vOL lineage cells in non-lesioned white matter was slightly
less at 6 months and 13 months than at 2 months and changed
only modestly or not at all following lesion induction (Figure 4B).
The net result was that dOL lineage cells, whichwere theminority
of OL lineage cells in pre-lesionwhitematter, came to outnumber
vOL lineage cells by 21 dpl. For example, in 2-month-old mice,
dOL lineage cells increased from 17% ± 2% of all OL lineage
cells in pre-lesion white matter to 45% ± 3% of the total at 21
dpl; in 13-month-old mice, they increased from 33% ± 6%
to 83% ± 4%over the same period. The latter might be an under-
estimate because the number of dOL lineage cells in 13-month-
old mice was still increasing at 21 dpl (Figure 4A).
Following lesion induction, the numbers of Ki67+ dOPs and
vOPs increased transiently at 5 dpl and/or 10 dpl, but declined
Figure 3. dOPs Dominate Remyelination of
the Corpus Callosum
(A) The non-lesioned corpus callosum is dominated
by TdTom+ dorsally derived OL lineage cells, with
infrequent GFP+ ventrally derived cells typically
clustered over the lateral walls of the lateral ven-
tricles. The inset shows a schematic depiction of
the location of the lysolecithin injection into the
corpus callosum.
(B) Corpus callosum 5 days after lysolecithin in-
jection: cellular infiltration is evident by the abun-
dance of Hst+ nuclei.
(C) Corpus callosum 21 days after lysolecithin in-
jection: the lesioned area is fully remyelinated with
a predominance of TdTom+ cells (lesioned area
marked by white dashed line).
(D) TdTom+ cells are more abundant than GFP+
cells within both the non-lesioned and lesioned
corpus callosum (p < 0.001 at all time points
and Student’s t test). The number of TdTom+
cells changed significantly over time (p < 0.001 and
one-way ANOVA), while the number of GFP+ cells
did not.
(E) Ki67+ cells in both TdTom+ and GFP+ cell populations show a significant change in with time (p < 0.001 TdTom+, p = 0.04 GFP+, and Kruskal-Wallis test).
There are no significant differences between the numbers of TdTom+ and GFP+ cells at any time point examined.
(F) There are significantly more TdTom+, CC1+ cells in both the NL and lesioned corpus callosum, compared with GFP+, CC1+ cells (p < 0.001 and Student’s
t test). The data are presented as mean ± SEM (n = 3 mice). The scale bars represent 100 mm.to pre-lesion levels by 21 dpl (Figures 4C and 4D). The peak pro-
liferative response was delayed in the 6-month- and 13-month-
old mice compared to the 2-month-old mice (Figures 4C and
4D). The extent of the peak proliferative response was greater
for dOPs than vOPs at all ages (Figures 4C and 4D). Therefore,
both the proliferative response and the ultimate contribution to
the total population was greater for dOL lineage cells than their
vOL counterparts, suggesting that dOPs are more adapted for
regeneration in the spinal cord.
dOPs Differentiate Less Efficiently in Spinal Cord
Lesions of Old versus Young Mice
To estimate the fraction of dOL and vOL lineage cells that
differentiated into OLs in ventral funiculus lesions, we immunola-
beled with antibody CC1. In 13-month-old mice, the number
of TdTom+, CC1+ dOLs was decreased at 5 dpl, whereas in
2-month- and 6-month-old mice, they increased slightly (Fig-
ure 4E). In mice of all ages, dOL numbers increased between 5
dpl and 21 dpl, and the final numbers of dOLs in lesions were
similar at all ages (Figure 4E). However, at 21 dpl the fraction of
the total TdTom+ cell population that immunolabeled for CC1
was significantly less in 13-month-old mice than in 2-month-old
mice (30% ± 7% versus 79% ± 9%) (Figure 4G). This demon-
strates that in 13-month-old mice, the majority of dOL lineage
cells in lesions at 21 dpl are undifferentiated dOPs and suggests
that the dOPs differentiate more slowly into dOLs in old versus
young animals. The fraction of the total TdTom+ population that
labeled for Periaxin did not change significantly with age (18%
± 2% at 2 months versus 24% ± 4% at 13 months; p = 0.21
and Student’s t test), suggesting that Schwann cell differentiation
is not affected by aging (Figure 4G).
In mice of all ages, the number of GFP+, CC1+ vOLs
decreased during the first 5 dpl, then increased between 5 dpland 21 dpl (Figure 4F). At 21 dpl, the fractions of all vOL lineage
cells that were CC1+ showed a slight decrease with age (87 ±
4% at 2 months and 70 ± 2% at 13 months) (Figure 4H). How-
ever, the proportion of GFP+ cells that labeled for Periaxin
showed a significant increase in the 13-month-old mice (8 ±
10%) compared with 2-month-old mice (30 ± 7%) (Figure 4H).
Thus, it appears that in contrast to dOPs, vOPs are recruited
less efficiently to spinal cord lesions in older mice, but their
rate of differentiation is not significantly compromised by age.
Dorsal OPs Show a Declining Efficiency of Recruitment
and Differentiation following Focal Demyelination of the
Aging Corpus Callosum
To assess the effect of aging on dorsal (cortical) versus ventral
forebrain populations of OL lineage cells and their contributions
to remyelination in the corpus callosum, focal demyelination was
induced in 6-month- (P170–P198, mean P192) and 13-month-
old (P390–P398, mean P393) mice. The density of TdTom+ cells
increased in the non-lesioned corpus callosum from 782 ± 185 to
1,029 ± 122 cells/mm2 between 2 months and 13 months, while
the density of GFP+ cells decreased from 117 ± 39 to 70 ± 37
cells/mm2 over the same period (Figures 5A and 5B). Following
focal demyelination, this trend continued; the density of TdTom+
cells at 10 dpl and 21 dpl increased modestly with age, while the
density of GFP+ cells decreased.
In mice of all ages, there was a marked proliferative response
of TdTom+ dOPs at 5 dpl, declining to pre-lesion levels by 21 dpl
(Figure 5C). The proliferative response of GFP+ vOPswas slower
in 2-month-old mice and practically non-existent in the older
(6-month-old and 13-month-old) mice (Figure 5D).
The density of TdTom+, CC1+ dOLs was reduced at 5 dpl in
mice of all ages and recovered subsequently, although failed
to regain their pre-lesion densities by 21 dpl (Figure 5E). InCell Reports 15, 761–773, April 26, 2016 765
Figure 4. Kinetics of Remyelination in the Aging Spinal Cord
(A) At all ages examined (2-, 6-, and 13-month-old mice), numbers of TdTom+ (dOL lineage) cells increase 5- to 6-fold postlesion, reaching a plateau at 10 dpl
(2-month-old mice) or after 21 dpl (13-month-old mice).
(B–D) In contrast, numbers of GFP+ (vOL lineage) cells do not change dramatically postlesion, except for a decrease at 5 dpl in 13-month-oldmice (B). Both dOPs
(C) and vOPs (D) undergo a transient proliferative response to demyelination, marked by increases in the numbers of Ki67+ OL lineage cells. The peak of pro-
liferation is delayed in 6-month- and 13-month-old mice relative to 2-month-old mice, indicating a slower regenerative response in older animals.
(E) TdTom+, CC1+ dOLs increase in number from 5 dpl to 21 dpl postlesion at all ages. The final numbers of CC1+ cells at 21 dpl are similar (p = 0.79 and one-way
ANOVA).
(F) Numbers of GFP+, CC1+ vOLs decrease sharply postlesion, but recover between 5 dpl and 21 dpl.
(G) The fraction of dOL lineage cells that are CC1+ dOLs at 21 dpl decreases markedly with age (from80% to30%; p = 0.008; and Student’s t test), indicating
that the rate of differentiation of dOPs is slower in older mice.
(H) The fraction of vOL lineage cells that are CC1+ vOLs at 21 dpl is90% in 2-month-oldmice compared to70% in 13-month-oldmice, implying amore similar
rate of differentiation of vOPs than dOPs in old versus young mice. The data are presented as mean ± SEM (n = 3 mice).contrast, the density of GFP+, CC1+ vOLs did not increase
significantly between 5 dpl and 21 dpl in the older (6-month-
old and 13-month-old) mice (Figure 5F). The proportion of
the TdTom+ cell population that co-labeled for CC1 at 21 dpl
was significantly decreased in 13-month-old mice relative to
2-month-old mice (from 35% ± 4% versus 79% ± 7%, respec-766 Cell Reports 15, 761–773, April 26, 2016tively) (Figure 5G), whereas the proportion of GFP+ cells that
was CC1+ was similar in young and old mice (Figure 5H). There-
fore, the dOPs are efficiently recruited into the lesion area, but
suffer a decline in their rate of OL differentiation, while vOPs
appear to be recruited less well, but retain their ability to differen-
tiate rapidly.
Figure 5. Kinetics of Remyelination in the Aging Corpus Callosum
(A) The number of TdTom+ cells in NL tissue is greater in older mice (combining data from 6-month-old and 13-month-old) (p = 0.031 and one-way ANOVA) and at
10 dpl (p = 0.002).
(B) The number of GFP+ cells decreases with age (p < 0.001 at 5 dpl and 10 dpl, p = 0.01 at 21 dpl, and one-way ANOVA).
(C) The number of TdTom+, Ki67+ cells decreases with age in NL corpus callosum (p = 0.002 and one-way ANOVA) and at 5 dpl (p = 0.004).
(D) The number of GFP+/Ki67+ cells decreaseswith age in the NL corpus callosum (p = 0.001 and one-way ANOVA) and at all times postlesion (5 dpl, p < 0.001; 10
dpl, p = 0.002; and 21 dpl, p < 0.001).
(E) The proportion of proliferating GFP+ cells at 5dpl is significantly fewer in 2-month-old animals compared to 12-month-old animals, but remains the same for
TdTom+ cells.
(F) The number of TdTom+/CC1+ dOLs is decreased in older mice at 21 dpl (p = 0.001 and one-way ANOVA).
(G) The number of GFP+/CC1+ cells decreases with age (NL, p = 0.015; 10 dpl, p = 0.001; 21 dpl, p = 0.034; and one-way ANOVA).
(H and I) The proportion of TdTom+ dOL lineage cells that is CC1+ at 21 dpl is less in old (13-month-old) than in young (2-month-old) mice (p < 0.001 and Student’s
t test), whereas (I) the proportion of vOL lineage cells that is CC1+ at 21 dpl is the same for old and young mice. The data are presented as mean ± SEM (n = 3).Dorsally and Ventrally Derived OL Lineage Cells Have
Different Functional Properties In Vitro
To investigate whether the different remyelination behaviors of
dOL versus vOL lineage cells are a result of cell-intrinsic differ-ences or an effect of local environmental factors, we studied
them in vitro where cells of both origins could be exposed to
the same environment. Dorsally and ventrally derived OL lineage
cells were isolated from whole brains of neonatal (P4–P6) andCell Reports 15, 761–773, April 26, 2016 767
Figure 6. Changes in the Properties of dOL
and vOL Lineage Cells In Vitro
(A and B) Migratory properties of dOL and vOL
lineage cells: no significant difference was de-
tected between the abilities of neonatal TdTom+
dOL versus neonatal GFP+ vOL lineage cells to
migrate across a transwell insert within 16 hr (A),
whereas significantly more adult (8-month-old)
TdTom+ cells migrated compared with adult GFP+
cells (p < 0.001 and Student’s t test) (B).
(C) EdU incorporation was the same for TdTom+
and GFP+ neonatal cells.
(D–F) Cultured neonatal cells of dorsal origin ex-
pressing TdTom, CNPase and MBP (merged) (D),
elaborating MBP+ myelin sheets (E), and express-
ing TdTom (F).
(G–I) Cultured neonatal cells of ventral origin ex-
pressing GFP, CNPase and MBP (merged) (G),
elaborating MBP+ myelin sheets (H), and ex-
pressing GFP (I).
(J) Adult TdTom+/CNPase+/MBP+OLwith primary
and secondary processes, but no myelin sheet
formation.
(K) Adult GFP+/CNPase+/MBP+ OL with no myelin
sheet formation.
(L) Significantly more neonatal TdTom+ dOL line-
age cells immunolabeled for CNPase, compared
with GFP+ vOL lineage cells (p = 0.007 and Stu-
dent’s t test).
(M) Similar fractions of neonatal TdTom+ andGFP+
cells immunolabeled for MBP.
(N) Significantly more adult TdTom+ dOL lineage
cells differentiated into CNPase+ OLs, compared
with GFP+ vOL lineage cells (p < 0.001 and Stu-
dent’s t test).
(O) Significantly more adult TdTom+ cells than
GFP+ cells differentiated into MBP+ OLs (p < 0.001
and Student’s t test). The data are presented as
mean ± SEM (n = 3).adult mice (mean age P232, 8-month-old) by fluorescence-acti-
vated cell sorting for TdTom or GFP fluorescence, respectively.
The cells were examined after 48 hr in culture; of the neonate
derived cultures, 87% ± 3% of TdTom+ cells and 96% ± 4%
of GFP+ cells expressed NG2 and 99% ± 1% of TdTom+ cells
and 97% ± 4% of GFP+ cells expressed Olig2, confirming the768 Cell Reports 15, 761–773, April 26, 2016high purity of the cell preparations and
demonstrating that the majority of OL line-
age cells were OPs, as expected at that
age. In the adult cell cultures, 76% ± 6%
of TdTom+ cells and 81% ± 4% of GFP+
cells expressed NG2 and 91% ± 3% of
TdTom+ cells and 94% ± 5% of GFP+
cells expressed Olig2. There was no sig-
nificant difference between the percent-
age of NG2+ cells in the neonate and adult
cultures, or between the percentage of
NG2+ cells in the TdTom+ and GFP+ pop-
ulations of both age groups.
To assess cellular migration, a transwell
assay was performed. In neonatal brain-derived cultures, there were no significant differences in the
numbers of TdTom+ or GFP+ cells that had migrated through
the membrane in the 16 hr of the experiment (Figure 6A). How-
ever, in the 8-month-old brain-derived cultures, significantly
more TdTom+ cells migrated through the membrane compared
with GFP+ cells (Figure 6B). These data suggest that adult brain
Figure 7. Genetic Ablation of Dorsally
Derived, Emx1+ Cells Leads to a Reduction
in the Number of CC1+ Cells at 21 dpl
(A–C) Ventral lesioned white matter showing
expression of Olig2, GFP and the nuclear marker
Hoechst dye (Hst) (A), GFP alone (B), and Olig2
alone (C). The percentage of Olig2+ cells (C) co-
expressing GFP (B) (merged in A) was found to be
95.9% ± 2.7%, confirming efficient transgene
expression in Emx1-Cre/Sox10-GFP-DTA corpus
callosum at 10 dpl (lesion demarcated by the white
dashed line).
(D–F) Ventral non-lesioned white matter showing
expression of GFP, TdTom, and Hst (D) and TdTom
alone (E) in triple transgenic Emx1-Cre/Sox10-
DTA/Sox10-GFP-TdTom mice, and expression of
GFP, TdTom, and Hst in control, non-ablated white
matter (F), revealing that the DTA ablation strategy
deleted the majority of Emx1+ cells from the CC.
The scale bar represents 100 mm.
(G) There was no significant difference between the
number of GFP+ cells in ablated and control mice
at any of the time points studied.
(H) No significant difference was detected in the
number of Olig2+ GFP+ cells at any time point.
(I) No significant difference was detected in the
number of Ki67+ GFP+ cells at any time point.
(J) There was a significant reduction in the CC1+
cell number at 21 dpl in the ablated mice compared
with controls (p = 0.007 and Student’s t test). The
data are presented as mean ± SEM (n = 3). The
scale bars represent 100 mm.derived dOPs migrate more readily in culture, compared to their
ventral counterparts.
To assess proliferative potential, neonatal cells were cultured
for 24, 48, 72, or 96 hr, before incubating for 6 hr in EdU.
Both TdTom+ and GFP+ cell populations incorporated EdU
to approximately the same extent (34%–62% of TdTom+
cells versus 32%–52% of GFP+ cells) (Figure 6C). Cells from
8-month-old brains were assessed after 96 hr in culture, but
very limited proliferation was detected; 0.9% ± 0.7% of TdTom+
cells stained positive for EdU and 1.1% ± 0.8% of GFP+ cells
(p = 0.423; Student’s t test). Therefore, no inherent difference
in proliferative potential was detected between the TdTom+
and GFP+ cell populations.
To assess differentiation efficiency and fate, the cells were
cultured for 8 days, fixed, and stained for 20,30-cyclic-nucleotide
30-phosphodiesterase (CNPase), a myelin-associated enzyme
expressed at the onset of OL differentiation, and myelin basic
protein (MBP), a major protein component of the myelin
sheath. Both TdTom+ dOPs and GFP+ vOPs differentiated intoCCNPase+, MBP+ cells with the classic
branching morphology of OLs. Neonatal
cells typically generated myelin sheets
(Figures 6D–6I), which were not observed
in the 8-month-old cell cultures (Figures
6J and 6K). In both neonatal and
8-month-old cell cultures, a significantly
greater proportion of TdTom+ cells differ-
entiated into CNPase+ OLs, compared with their GFP+ counter-
parts (Figures 6L and 6N). Of the neonatal OLs that expressed
CNPase, similar numbers of TdTom+ and GFP+ cells co-ex-
pressed MBP. However, in the 8-month-old cultures, a signifi-
cantly greater fraction of TdTom+, CNPase+ cells than GFP+,
CNPase+ cells co-expressed MBP (Figure 6H). These data sug-
gest that dOPs differentiate more readily into MBP+ dOLs in cul-
ture, compared to their ventral counterparts.
Genetic Ablation of Dorsally Derived OL Lineage Cells
Causes a Reduction in Remyelination Efficiency
A genetic ablation strategy was used in which Emx1-positive
dOPs and dOLs were eliminated at source by the targeted
expression of diphtheria toxin A fragment (DTA). 2-month-old
(P61–P74, mean age P67) mice carrying the Em1-Cre and
Sox10-GFP-DTA transgenes were used, in which GFP is excised
along with a poly(A) signal following Cre recombination, thus
activating DTA and killing the cell (Kessaris et al., 2006)(Figures
7A–7C). To determine the efficiency of Cre recombination andell Reports 15, 761–773, April 26, 2016 769
the associated deletion of Emx1-positive cells, the Emx1-Cre
line was crossed to both the Sox10-DTA and the Sox10-GFP-
TdTomato lines. In the triple transgenic offspring, Emx1 expres-
sion by dorsally derived cells should result in recombination and
expression of DTA. Any cells escaping DTA expression would
be expected to label with TdTomato and hence provide an indi-
cation of the success of this genetic deletion strategy (Figures
7D–7F). 8.9 ± 3.5 TdTomato-positive cells per 101 mm2 were
present in the triple transgenic mice, compared to 78.2 ± 18.5
cells per 101 mm2 in control mice (Emx1-Cre/Sox10-GFP-
TdTomato). This would suggest that 85 ± 5.5% of the Emx1-
positive population was destroyed at source with the inducible
DTA genetic deletion strategy.
Lysolecithin injection into the corpus callosum was performed
to create a focal area of demyelination, and the subsequent
remyelination process was compared between Emx1-Cre/
Sox10-DTA ablated mice and control animals (Sox10-DTA). No
significant difference was detected in the total GFP+ cell number
between ablated and control animals at any time point (Fig-
ure 7G). Nor did we detect a difference in the number of
Olig2+, GFP+ cells (Figure 7H), nor in the number of Ki67+,
GFP+ cells (Figure 7I). However, there were significantly fewer
CC1+ cells in ablated animals compared to controls at 21 dpl
(32.5 ± 3 cells/mm2 in control animals, compared with 26.4 ±
2 cells/mm2 in ablated animals; p = 0.007 and Student’s t test)
(Figure 7J). This suggests an impairment of the differentiation
phase of remyelination in the ablated mice.
DISCUSSION
OPs emerge from discrete parts of the ventral and dorsal VZ in
the embryonic spinal cord and forebrain (Cai et al., 2005; Fogarty
et al., 2005; Vallstedt et al., 2005; Kessaris et al., 2006; reviewed
by Richardson et al., 2006). Previous studies have identified
similar electrophysiological properties of the ventrally and
dorsally derived populations of both spinal cord and brain
(Clarke et al., 2012; Tripathi et al., 2011). Moreover, when
ventrally or dorsally derived OL lineage cells in the developing
forebrain were ablated by targeted DTA expression, the remain-
ing population(s) proliferated and migrated more than normal
to compensate for the loss (Kessaris et al., 2006). These obser-
vations suggested that OL lineage cells derived from different
parts of the VZ are functionally equivalent and can substitute
for one another during development. However, the possibility re-
mained that there might be functional differences that only
become apparent during pathology. In support of the latter
idea, Zhu et al. (2011) demonstrated that, in response to a
focal demyelination injury in the ventral spinal cord, an unexpect-
edly large number of newly differentiated OLs were dorsally
derived, suggesting that dOL lineage cells might be particularly
adapted for remyelination. To investigate this possibility further,
we made use of a dual-reporter mouse line in which OL lineage
cells can be differentially marked according to their sites of origin
in the ventral or dorsal VZ, allowing side-by-side comparison of
their differentiation and remyelination capacities in vivo and
in vitro.
In the normal adult spinal cord, the ventral funiculus is domi-
nated by pMN-derived OL lineage cells with infrequent cells770 Cell Reports 15, 761–773, April 26, 2016from the dorsal VZ. However, in response to focal demyelination
in the ventral funiculus, the rare dOPs undergo a marked prolif-
erative response, with prompt recruitment into the lesion core
and differentiation into mature OLs, so that by 60 dpl, dorsally
derived cells outnumber their ventrally derived counterparts
and are the major player in the oligodendrocyte remyelination
response. This also applies to the component of spinal cord
demyelination that is mediated by Schwann cells where dorsally
derived cells are the dominant contributors. It is uncertain
whether this reflects an inherent propensity for these cells to
differentiate into Schwann cells compared with ventrally derived
cells or whether this is simply a function of their greater prolifer-
ative response resulting in greater numbers of dorsally derived
cells residing within the lesion niches where Schwann cell re-
myelination occurs (Zawadzka et al., 2010).
As in the spinal cord, ventrally and dorsally derived OP popu-
lations sequentially populate the developing forebrain, raising
the question of whether similar differences might be detected
in their relative responses to demyelination in the adult forebrain.
The corpus callosum and adjacent subcortical white matter is
populated mainly by cortex-derived dorsal OL lineage cells
with an 20% contribution of OL lineage cells from the ventral
forebrain (Tripathi et al., 2011).Whenwe induced focal demyelin-
ation in the corpus callosum, the remyelination response was
dominated by the dorsal (cortex-derived) population. A marked
proliferative response of dOPs was detected at 5 dpl, with differ-
entiation into CC1+ dOLs and restoration of pre-lesion numbers
of dOL lineage cells complete by 21 dpl. On the other hand, while
numerous Ki67+ vOPswere detected in the lesion at 5 dpl and 10
dpl, very few of these seemed to differentiate into CC1+ vOLs,
presumably persisting as vOPs in the longer term. Thus, in the
corpus callosum, both dOPs and vOPs react differently to demy-
elination, with dOPs demonstrating a strong regenerative pro-
pensity. However, due to their predominance in this tract, it is
not possible to determine whether dorsally derived progenitors
made a disproportionately high contribution to remyelination
compared with their ventral counterparts, as is the case in the
ventral spinal cord.
The rate of remyelination is strongly reduced in aged animals.
We asked whether this age-related decline is a function of either
the dorsal or ventral population of OL lineage cells, or both. We
created demyelinated lesions in the spinal cords (ventral funic-
ulus) of older mice (6-months-old or 13-months-old) and as-
sessed the response of the dorsally and ventrally derived OL
populations. Comparing remyelination of lesions in older versus
younger mice, we found that dOPs were more efficiently re-
cruited in older animals, but their ability to differentiate into
CC1+ OLs was reduced. In contrast, vOPs were less efficiently
recruited into lesions in the older mice but, once recruited,
their ability to differentiate was unhindered. Thus, the two
populations show very different age-associated functional
changes. However, the final density of differentiated OLs within
remyelinated spinal cord lesions was the same in older versus
younger mice, suggesting that increased recruitment of dOPs
compensates for their reduced differentiation capacity. Shen
et al. (2008) have demonstrated an age-associated decrease
in histone deacetylase (HDAC) recruitment, leading to pro-
longed expression of differentiation inhibitors, and ultimately
an impairment of OP differentiation. Perhaps HDAC recruitment
failure is more pronounced in the dOP population and results in
increased susceptibility to age-associated differentiation block.
Despite an apparent age-associated slowing in the rate of differ-
entiation, it remains a possibility that the proportion of dorsally
derived OLs increases over the more prolonged course of re-
myelination in aged animals.
In the aging corpus callosum, dOPs continued to dominate the
remyelination process, remaining themore numerous population
both within the lesion and in neighboring unlesioned tissue. We
detected an age-associated decline in recruitment of dOPs
into the lesion, as well as a decline in the number of Ki67+ prolif-
erating dOPs and of CC1+ dOLs. In line with the reduced prolif-
eration index, the proportion of dOPs that had differentiated by
21 dpl also decreased with aging. Thus, as for the spinal cord,
there is an age-associated decline in the proliferation/differenti-
ation activity of the dOP population. This is consistent with the
overall age-related decline in OP proliferation rates—coupled
to declining rates of production of differentiated OLs—in the
normal healthy mouse (Psachoulia et al., 2009; Lasiene et al.,
2009; Young et al., 2013)
vOPs decreased in total number within the non-lesioned and
lesioned corpus callosum, demonstrating a corresponding
reduction in their proliferation response to focal demyelination.
However, the aged vOPs appeared to be able to maintain a
high efficiency of differentiation into CC1+ OLs by 21 dpl. There-
fore, vOPs in the aging corpus callosum, as in the aging spinal
cord, show a sustained differentiation capacity with advancing
age.
The different settling patterns of dorsal and ventral OPs and
OLs within the adult CNS raised the possibility that their func-
tional heterogeneity might be the result of extrinsic environ-
mental factors, rather than intrinsic properties of the cells them-
selves. To investigate this possibility, the two populations were
FACS-purified and cultured under identical conditions. In both
neonatal and adult brain-derived cultures, we found differences
in the in vitro properties of the ventrally and dorsally derived cells.
Adult brain dOPs showed reduced viability and very little prolifer-
ation, so limiting the total cell numbers obtained and hence the
number of factors and time points that could reasonably be
tested. Nevertheless, adult dOPs showed enhanced migration,
an increased tendency to differentiate toward an OL fate, and
a greater efficiency of differentiation into MBP-positive OLs
compared to their ventral counterparts. Therefore, in vitro anal-
ysis confirmed that dorsal and ventral OPs differ intrinsically;
the two populations show different migration and differentiation
capacities when in an identical environment. This heterogeneity
appeared to become more apparent in the adult brain,
compared with the neonatal brain, and may reflect a differential
susceptibility of the two populations to aging changes, as iden-
tified in vivo.
No differences were detected in the proliferation capacities of
the two populations, conflicting with the in vivo finding of a
greater proliferative response in dOPs following focal demyelin-
ation. The microenvironment created by demyelination is not a
feature of the cell culture and so this discrepancy may reflect
the fact that both populations proliferate to a similar extent in cul-
ture medium, but dOPs show enhanced responsiveness to ademyelinating insult, mediated via enhanced proliferation
initially.
We cannot exclude the possibility that the apparent efficiency
of differentiation of the dOPs may be a function of the greater
number of proliferating precursors from the dorsally derived
pool. However, our in vitro studies reveal that in an identical envi-
ronment, with an equivalent proportion of Ki67+ proliferating
cells, the dOPS demonstrate a greater efficiency of differentia-
tion into MBP-positive OLs compared to their ventral counter-
parts. If these properties persist in vivo, the dOP contribution
to remyelination is likely to be a result of increased efficiency of
both recruitment and differentiation. Such synergism could
feasibly prime the cells for an optimal response to a demyelin-
ating insult.
The rapid proliferative response of dOPs following focal demy-
elination shares features characterized by transit amplifying cells
of the hematopoietic system. Transit amplifying cells are partially
lineage-committed and are able to respond rapidly to injury with
a prompt proliferative response and rapid regeneration of the
compromised cell type. Our in vitro analysis (this study) revealed
a greater tendency for dOPs to generate OLs compared with
their ventral counterparts. Further studies to characterize the
molecular markers and gene expression profiles of the two OP
populations might shed further light on their phenotypic differ-
ences and the reasons behind them.
A genetic ablation strategy was applied to the forebrain and 85
± 5.5% of Emx1+ dorsally derived cells were destroyed at
source. The proliferation and recruitment phases of remyelina-
tion appeared to be unaffected, suggesting that either the
ventrally derived population or the surviving 15 ± 5.5% of
dorsally derived cells were able to compensate in the early
stages of remyelination. However, there was a modest reduction
in the number of CC1+ OLs within the lesion at 21 dpl in ablated
animals compared with control. Therefore, ablation of 85% of
dOPs is sufficient to interfere with the differentiation phase of re-
myelination, suggesting a failure of compensation by the vOPs.
Future studies to address the extent of this failure of compensa-
tion, particularly in the context of aging, may provide further
insight into the functional heterogeneity of the dorsal and ventral
populations.
In conclusion, the developmental heterogeneity of OPs deter-
mines their phenotypic properties in the adult CNS. The cells’
response to demyelination, contribution to remyelination, and
susceptibility to age-associated functional decline is influenced
by their developmental origin. Analysis of the gene expression
profiles of the dorsal and ventral OPs, in both the diseased and
aging environments, could reveal potential targets for therapeu-
tic enhancement of remyelination, particularly with regard to
overcoming the age-associated decline in the efficiency of differ-
entiation of OPs into mature, myelinating OLs.
EXPERIMENTAL PROCEDURES
Transgenic Mice
Sox10-loxP-eGFP-polyA-loxP-TdTomato reporter mice (Sox10-GFP-TdTom)
express enhanced GFP in all OL lineage cells (OPs and OLs) in the absence
of Cre activity. They were crossed to either Msx3-Cre (Fogarty et al., 2005)
or Emx1-Cre (Kessaris et al., 2006) lines to induce TdTom expression in OPs
developing from the dorsal spinal cord VZ or the cortical VZ, respectively.Cell Reports 15, 761–773, April 26, 2016 771
To study the effect of genetically ablating the dorsally derived, Emx1-positive
cells of the forebrain, the Emx1-Cre line was crossed to the Sox10-loxP-GFP-
poly(A)-loxP-DTA mouse (Kessaris et al., 2006).
Mice were kept on a 12 hr dark/light cycle and the day of birth designated
P0. All animal experiments conformed to the UK Animals (Scientific Proce-
dures) Act 1986 and were approved by the UCL or Cambridge University local
ethical committees before licensing by the UK Home Office.
Spinal Cord Demyelination
A focal area of primary demyelination was created in the caudal thoracic
ventral funiculus of the spinal cord by injection of 1% (v/v) lysolecithin (Wood-
ruff et al., 2004; Zawadzka et al., 2010). Animals of equivalent age that had not
undergone surgery provided non-lesioned controls.
Corpus Callosum Demyelination
General anesthesia and perioperative analgesia were provided as for the spi-
nal cord demyelination model. Using a Stoetling stereotactic frame, the dorsal
aspect of the skull was clipped and surgically prepared. A midline incision was
made from just caudal to the eyes to the occipital crest. A small hole was drilled
in the skull at 0.08 mm lateral and 0.05 mm rostral to Bregma. Unilateral injec-
tion of 2 ml of 1% (v/v) lysolecithin was delivered at a depth of 0.24 mm below
the brain surface, into the corpus callosum, using a 5 ml Hamilton syringe. The
needle was left in position for 3 min to allow toxin dispersal. Mice were placed
in a warm incubator and monitored for full recovery.
In Vivo EdU Assay
Following lysolecithin injection, mice received EdU (5-ethynyl-20-deoxyuridine,
Invitrogen) by intraperitoneal injection (50 mg/gram of body weight/day) on 2
consecutive days. Treated mice were sacrificed 24 hr after the second EdU
dose. Tissue sections were stained using the ‘‘Click-iT Plus’’ EdU Alexa Fluor
647 Imaging Kit (Invitrogen).
Tissue Processing
Mice were terminally anaesthetized and fixed by intracardiac perfusion at 5,
10, 21, or 60 dpl induction using 4% (w/v) paraformaldehyde (PFA) in 0.1 M
PBS. Spinal cords or brains were removed, postfixed in 4% PFA for 2 hr at
20C–25C, cryoprotected with 20% (w/v) sucrose for 24–48 hr, embedded
and frozen in OCT medium, and stored at 80C. Tissues were sectioned at
12 mm and collected onto poly-L-lysine-coated glass slides.
Immunocytochemistry and Microscopy
Spinal cord sections were pre-treated with blocking solution (8% [v/v] normal
goat serum and 0.1% [v/v] Triton X-100 in PBS], incubated with primary anti-
bodies overnight at 4C, and then secondary antibodies for 2 hr at 20C–25C.
The following primary antibodies were used at 1:1,000 dilution unless stated
otherwise: GFP (chicken, Aves lab), Olig2 (rabbit, Millipore), CC-1 (anti-adeno-
matous polyposis coli, APC) (mouse, 1:100, Calbiochem), Nkx2.2 (mouse,
1:200, DSHB), NG2 (rabbit, 1:200, Millipore), Ki67 (rabbit, Abcam), Periaxin
(rabbit, 1:3,000, from Peter Brophy, Centre for Neuroscience Research, Uni-
versity of Edinburgh, UK), SCIP/Oct-6 (rabbit, 1:4,000, from Dr. John Berming-
ham Jr., McLaughlin Research Institute, Montana, USA), MBP (rat, 1:350, Se-
rotec). Secondary antibodies were: Alexa Fluor 488-, 568-, or 647-conjugated
goat antibodies against mouse, rat, rabbit, chicken, or goat IgG or IgG2b
(1:1,000, all from Invitrogen). Cell nuclei were visualized by poststaining with
Hoechst 33258 (Sigma, 1:1,000). For cell counts, at least three sections per an-
imal from three to six mice were examined using a Leica SP5 confocal micro-
scope. Data are quoted as mean ± SEM.
Statistical analysis was performed using the Statistical Package for the So-
cial Sciences software. The data were analyzed for normal distribution and in-
teractions. A two-tailed Student’s t test was performed to assess the statistical
significance of the variation in single time point cell counts. The cell type and
the time point were found to interact and so were analyzed separately. To
determine the significance of changes in the cell types over multiple time
points, one-way and two-way ANOVAs were performed, with Bonferroni and
Tamhane post hoc tests as appropriate based on the presence of homogene-
ity of variance. Where data were not normally distributed, a Mann-Whitney
U-test or Kruskal-Wallis test was performed. Significance levels were set at772 Cell Reports 15, 761–773, April 26, 20165% and the data are presented graphically as: *(p < 0.05), **(p < 0.01), and
***(p < 0.001).
OP Isolation and Culture
Brains from adult mice (6- to 9-months-old) were placed into cold Neuro-
basal medium (NB) (Gibco) with 1% (v/v) penicillin streptomycin (Sigma),
cut into small fragments, and transferred to a digestion mix consisting of
4 ml of NB, 160 ml papain (Worthington), 40 ml DNase 1 Type IV (Sigma),
and 40 ml of L-cysteine (Sigma). The tissue was incubated at 37C for 1 hr
in the digestion solution, followed by mechanical dissociation using
serum-coated, fire polished glass pipettes. The papain was inactivated by
trituration in 3 ml of NB containing 500 mg/ml of BSA Fraction V (i.e.,
25 mg) (Sigma), 40 mg/ml of DNase I Type IV, and 1 mg/ml of trypsin inhibitor
(Sigma) and diluted in 20 ml NB before centrifugation for 8 min at 250 3 g.
The pellet was resuspended in 15 ml NB and passed through a 70 mm pore-
diameter nylon filter to achieve a single cell suspension. The cell suspension
was resuspended in a 30% (w/v) Percoll solution (GE Healthcare) and centri-
fuged at 800 3 g for 20 min. The top myelin fraction was aspirated and dis-
carded, allowing collection of the OL-rich layer, which was diluted in 100 ml
NB and centrifuged at 250 3 g for 8 min. The cell pellet was resuspended in
neuronal media for optogenetics (NEMO, Cell Guidance Systems UK) and
supplements for optogenetic survival (SOS, Cell Guidance Systems UK),
supplemented with 1% (w/v) DNase, 5% (w/v) BSA (Sigma), 20 ng/ml basic
fibroblast growth factor (bFGF/ Fgf-2; Peprotech), and 20 ng/ml platelet
derived growth factor (Pdgf-AA; Peprotech). FACS was used to isolate the
GFP-positive and TdTom-positive populations using a three laser MoFlo cy-
tometer and cells were collected into NEMO-SOS containing 1% (v/v) peni-
cillin streptomycin and PDGF/FGF (each at 20 ng/ml). Cells were seeded at
50,000 per 12 mm plastic coverslip (Thermoscientific). Wells and coverslips
had been pre-coated with 0.05% (w/v) polyornithine (Sigma) for 3 hr at 37C,
rinsed with sterile distilled water, and incubated with 5 mg/ml laminin (Sigma)
diluted in Hank’s buffered salt solution (HBSS, GIBCO) for 3 hr at 37C.
Cells were maintained in 8.5% (v/v) CO2 at 37
C. Growth factors were
supplemented daily for 2 days and the medium then switched to NB media
containing 1% (v/v) GlutaMAX (Gibco,), 2% (v/v) B27 (Gibco), 50 mg/ml apo-
transferrin (Sigma), 0.2% (w/v) bovine pancreatic insulin (Sigma), 1% (v/v)
penicillin streptomycin, 0.1% (w/v) N-acetylcysteine (Sigma), and PDGF/FGF
(concentrations as above). To study cell proliferation, PDGF and FGF were
added daily and the medium changed every other day. Cells were then incu-
bated for 6 hr in 10 mM EdU and fixed in 4% (w/v) PFA at 20C–25C for
10 min and rinsed in PBS. To study cell differentiation, the growth factors
were withdrawn after 48 hr and the medium changed every other day for a
further 6 days before fixation. The immunofluorescence labeling protocol
was used as described above for tissue sections, with the additional use of
the following primary antibodies: GFAP (rabbit, 1:500, Dako) and CNPase
(mouse, 1:200, AbCam).
Cell migrationwas assessed by seeding 10,000 cells onto an 8 mmpore size,
PET cell culture insert (Millipore). The insert was placed into a well containing
NEMO-SOS plus PDGF/FGF (each at 30 ng/ml) and incubated in 8.5% (v/v)
CO2 at 37
C for 16 hr before fixation. Cell nuclei were visualized by poststain-
ingwith Hoechst 33258. Cells that had successfullymigrated were imaged and
quantified.
Neonatal OPs were isolated, cultured, and analyzed as for the adult cells,
except that the Percoll gradient centrifugation was replaced by a wash in
1 ml of 4% (w/v) BSA in NB medium.
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